These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22946091)

  • 1. Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production.
    Shimada K; Hirano E; Kimura T; Fujita M; Kishimoto C
    Exp Biol Med (Maywood); 2012 Sep; 237(9):1039-44. PubMed ID: 22946091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production.
    Shimada K; Murayama T; Yokode M; Kita T; Fujita M; Kishimoto C
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):672-8. PubMed ID: 20399087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine reduces the severity of atherosclerosis in apolipoprotein E-deficient mice by reducing superoxide production.
    Shimada K; Murayama T; Yokode M; Kita T; Uzui H; Ueda T; Lee JD; Kishimoto C
    Circ J; 2009 Jul; 73(7):1337-41. PubMed ID: 19436121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice.
    Baumhäkel M; Custodis F; Schlimmer N; Laufs U; Böhm M
    Atherosclerosis; 2010 Sep; 212(1):55-62. PubMed ID: 20347444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
    Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
    J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
    Okabe TA; Shimada K; Hattori M; Murayama T; Yokode M; Kita T; Kishimoto C
    Cardiovasc Res; 2007 Jun; 74(3):537-45. PubMed ID: 17374527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
    Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
    Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
    Takaya T; Kawashima S; Shinohara M; Yamashita T; Toh R; Sasaki N; Inoue N; Hirata K; Yokoyama M
    Atherosclerosis; 2006 Jun; 186(2):402-10. PubMed ID: 16157344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
    Yao R; Cheng X; Liao YH; Chen Y; Xie JJ; Yu X; Ding YJ; Tang TT
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):188-95. PubMed ID: 18287887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.
    Lee IO; Kratz MT; Schirmer SH; Baumhäkel M; Böhm M
    J Pharmacol Exp Ther; 2012 Nov; 343(2):253-7. PubMed ID: 22837011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sodium intake increases vascular superoxide formation and promotes atherosclerosis in apolipoprotein E-deficient mice.
    Ketonen J; Merasto S; Paakkari I; Mervaala EM
    Blood Press; 2005; 14(6):373-82. PubMed ID: 16403692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
    Ma XL; Yue TL; Lopez BL; Barone FC; Christopher TA; Ruffolo RR; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):128-36. PubMed ID: 8613909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ
    J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
    Bhatt P; Makwana D; Santani D; Goyal R
    Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.